Therefore, although the treatment effects were numerically small, the improvement in HbA1c and the reduced need to initiate insulin treatment that was observed with sacubitril/valsartan in this secondary analysis may benefit people with heart failure and diabetes. Here, INS is linked to diabetes mellitus.